CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
miraDry +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01811004
NCT01811004N/ACompleted

Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis

Cynosure, Inc.·interventional·Posted Mar 14, 2013·Updated Jan 22, 2021

In Brief

A clinical study evaluating miraDry, Nd:YAG Laser, and 1 other intervention for Hyperhidrosis. Completed, enrolled 17 participants across 1 site.

Detailed Summary

The Purpose of the study is to evaluate the 1440nm Laser Assisted Selective Photothermolysis vs. Botulinum Toxin or miraDry® Microwave Thermolysis For Treatment of Axillary Hyperhidrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperhidrosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 14, 2013
Enrollment StartSep 1, 2012
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.3 years ago

Interventions

miraDrydevice

miraDry

Nd:YAG Laserdevice

Nd:YAG 1440 nm Laser

Botox®device

Botox®